Related Experiment Video

Updated: Feb 3, 2026

Live Cell Imaging of Early Autophagy Events: Omegasomes and Beyond
09:00

Live Cell Imaging of Early Autophagy Events: Omegasomes and Beyond

Published on: July 27, 2013

19.2K

EGFR-Signaling and Autophagy: How they Fit in the Cancer Landscape

Amar B Singh1

  • 1Department of Biochemistry and Molecular Biology, Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center and VA Nebraska-Western Iowa Health Care System, Omaha, NE, USA.

Journal of Adenocarcinoma
|October 30, 2018
PubMed

Insights

Autophagy plays a critical role in cancer cells developing resistance to Epidermal Growth Factor Receptor (EGFR) therapies. Understanding the complex relationship between EGFR signaling and autophagy is crucial for improving anti-EGFR cancer treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Signaling

Background:

  • Epidermal Growth Factor Receptor (EGFR) signaling is crucial in epithelial cancers, making it a primary therapeutic target.
  • Anti-EGFR therapies show initial efficacy but often face resistance due to complex cellular signaling.
  • Autophagy, a cellular degradation process, is increasingly recognized for its role in mediating resistance to anti-EGFR cancer treatments.

Purpose of the Study:

  • To investigate the intricate molecular mechanisms linking EGFR signaling and autophagy in the context of cancer therapy resistance.
  • To elucidate how EGFR regulates autophagy, influencing cancer cell survival and growth under therapeutic pressure.

Main Methods:

  • Review of existing literature on EGFR signaling pathways.
  • Analysis of studies investigating the role of autophagy in cancer cell resistance.
  • Exploration of context-dependent and kinase-dependent/independent regulation of autophagy by EGFR.

Main Results:

  • EGFR signaling is implicated in cancer aggressiveness and prognosis.
  • Cancer cells develop resistance to anti-EGFR therapy through feedback activation of pro-survival pathways.
  • EGFR regulates autophagy in a context-dependent manner, influencing tumor survival and growth.

Conclusions:

  • A deeper understanding of the EGFR-autophagy nexus is essential for overcoming therapeutic resistance.
  • Targeting or modulating autophagy may represent a viable strategy to enhance the efficacy of anti-EGFR therapies.
  • Further research into the molecular details of EGFR's regulation of autophagy is critical for advancing clinical cancer treatment.
Keywords:
AutophagyCarcinogenesisEGFRMetabolic stressTreatment resistance

More Related Videos

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids08:52

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids

Published on: November 22, 2021

4.6K
Activating Autophagy by Aerobic Exercise in Mice08:44

Activating Autophagy by Aerobic Exercise in Mice

Published on: February 3, 2017

12.7K

Related Concept Videos

Induced-fit Model01:13

Induced-fit Model

Most chemical reactions in cells require enzymes—biological catalysts that speed up the reaction without being consumed or permanently changed. They reduce the activation energy needed to convert the reactants into products. Enzymes are proteins, that usually work by binding to a substrate—a reactant molecule that they act upon.
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
89.2K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.8K
Inclusive Fitness00:57

Inclusive Fitness

Most altruistic behavior—in which one animal helps another at a cost to themselves—occurs between relatives. Scientists think these altruistic behaviors evolved because they increase the inclusive fitness of the animal providing help.
41.2K
Goodness-of-Fit Test01:16

Goodness-of-Fit Test

The goodness-of-fit test is a type of hypothesis test which determines whether the data "fits" a particular distribution. For example, one may suspect that some anonymous data may fit a binomial distribution. A chi-square test (meaning the distribution for the hypothesis test is chi-square) can be used to determine if there is a fit. The null and alternative hypotheses may be written in sentences or stated as equations or inequalities. The test statistic for a goodness-of-fit test is given as...
9.2K
Expected Frequencies in Goodness-of-Fit Tests01:19

Expected Frequencies in Goodness-of-Fit Tests

A goodness-of-fit test is conducted to determine whether the observed frequency values are statistically similar to the frequencies expected for the dataset. Suppose the expected frequencies for a dataset are equal such as when predicting the frequency of any number appearing when casting a die. In that case, the expected frequency is the ratio of the total number of observations (n)  to the number of categories (k).
8.7K